Takafumi Nakatsu
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comparative long-term follow-up study of persistence of immunity after JVC-001 measles, mumps, and rubella vaccination in Japanese children.
Journal: Human vaccines & immunotherapeutics
Published: November 21, 2025
Phase III, open-label, single-arm study of a new MMR vaccine (JVC-001); measles AIK-C, mumps RIT 4385, rubella Takahashi, as a second vaccine dose in healthy Japanese children aged 5-6 years.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: February 14, 2024
Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study.
Journal: Advances in therapy
Published: September 30, 2022
Safety, Pharmacokinetics and Pharmacodynamics of DS-1040, in Combination with Thrombectomy, in Japanese Patients with Acute Ischemic Stroke.
Journal: Clinical drug investigation
Published: November 28, 2021
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects.
Journal: BMC pharmacology & toxicology
Published: January 15, 2020
Effects of itraconazole and rifampicin on the single-dose pharmacokinetics of the nonsteroidal mineralocorticoid receptor blocker esaxerenone in healthy Japanese subjects.
Journal: British journal of clinical pharmacology
Published: November 21, 2019
Absolute Bioavailability of Esaxerenone and Food Effects on its Pharmacokinetics After a Single Oral Dose in Healthy Japanese Subjects: An Open-Label Crossover Study.
Journal: Advances in therapy
Published: February 26, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026